Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma

British Journal of Surgery

Volumn 98, Issue 4, 2011, Pages 552-557

  Eguchi, S ^a   Kanematsu, T ^a   Arii, S ^b   Omata, M ^c   Kudo, M ^d   Sakamoto, M ^e   Takayasu, K ^f   Makuuchi, M ^g   Matsuyama, Y ^h   Monden, M ⁱ  

^a NAGASAKI UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Yamanashi Prefectural Central Hospital   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g Japanese Red Cross Medical Centre   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; DECARBOXYPROTHROMBIN; PROTEIN PRECURSOR; PROTHROMBIN;

AGED; ARTICLE; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; TUMOR RECURRENCE;

AGED; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTEIN PRECURSORS; PROTHROMBIN;

EID: 79952006805     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7393     Document Type: Article

References (16)

1. Murray CJ, Lopez AD,. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276. (Pubitemid 27192468)
2. Tsunoda T, Segawa T, Eto T, Izawa K, Tsuchiya R,. Long-term survivors after hepatectomy for hepatocellular carcinoma. J Gastroenterol Hepatol 1990; 5: 595-600.
3. Zhou XD, Tang ZY, Ma ZC, Fan J, Wu ZQ, Qin LX, et al., Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases. J Cancer Res Clin Oncol 2009; 135: 1067-1072.
4. Fukuda S, Itamoto T, Amano H, Kohashi T, Ohdan H, Tashiro H, et al., Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. World J Surg 2007; 31: 345-352. (Pubitemid 46183522)
5. Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu CL, et al., Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 2001; 19: 3037-3044. (Pubitemid 32565441)
6. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211: 277-287.
7. The Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer (4th edn). Kanehara: Tokyo, 2000.
8. Shimada M, Rikimaru T, Hamatsu T, Yamashita Y, Terashi T, Taguchi K, et al., The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg 2001; 182: 177-182. (Pubitemid 32907357)
9. Kokudo N, Makuuchi M,. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 2009; 44 (Suppl 19): 119-121.
10. Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do KA, et al., Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001; 136: 528-535. (Pubitemid 32417542)
11. Chen JY, Chau GY, Lui WY, Tsay SH, King KL, Wu CW,. Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection. World J Surg 2003; 27: 294-298.
12. Hidaka M, Eguchi S, Okudaira S, Takatsuki M, Soyama A, Tokai H, et al., Multicentric occurrence and spread of hepatocellular carcinoma in whole explanted end-stage liver. Hepatol Res 2009; 39: 143-148.
13. Eguchi S, Hidaka M, Tomonaga T, Miyazaki K, Inokuma T, Takatsuki M, et al., Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantation. J Gastroenterol 2009; 44: 624-629.
14. Shimada K, Sano T, Sakamoto Y, Kosuge T,. A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 2005; 104: 1939-1947. (Pubitemid 41513178)
15. Shirabe K, Shimada M, Kajiyama K, Gion T, Ikeda Y, Hasegawa H, et al., Clinicopathological features of patients with hepatocellular carcinoma surviving > 10 years after hepatic resection. Cancer 1998; 83: 2312-2316. (Pubitemid 28533500)
16. Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, Omata M, et al., Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008; 143: 469-475. (Pubitemid 351406380)